FDA Investigator: Wendy G. Tan
- Wendy G. Tan first started conducting FDA inspections in 2017, with the last inspection in 2023. Over that time, Wendy G. Tan has conducted 20 inspections at 20 companies across 20 sites.
Get Wendy Tan's official FDA inspection documents. Gain valuable insights from their Form 483s and EIRs to ace your next inspection.
Documents
Upon purchase, you will receive an email with a link to immediately download the documents.
FDA 483 GlaxoSmithKline dba Human Genome Sciences | Dec 2023
Available Now - $199
Wendy G. Tan
Human Drugs Form 483
FDA 483 Catalent Indiana, Bloomington | November 2023
Available Now - $199
Wendy G. Tan
Human Drugs Form 483
FDA 483 Woodstock Sterile Solutions, Woodstock | March 2022
Available Now - $199
Wendy G. Tan
Human Drug Form 483
FDA 483 AstraZeneca AB, Sodertalje | December 2021
Available Now - $199
Wendy G. Tan
Human Drug Form 483
FDA 483 Xellia Pharmaceuticals USA, Bedford | January 2020
Available Now - $199
Wendy G. Tan
Human Drug Form 483
FDA 483 Fresenius Kabi USA, Grand Island | February 2017
Available Now - $199
Wendy G. Tan
Human Drug Form 483
FDA 483 Evive Biopharmaceutical (Beijing), Ltd., Beijing | 2023
Out-of-stock
Wendy G. Tan
Human Drugs Form 483
FDA 483 Suzhou Union Biopharm Co., Ltd., Suzhou | 2023
Out-of-stock
Wendy G. Tan
Human Drugs Form 483
FDA 483 Rentschler Biopharma Inc., Milford | 2023
Out-of-stock
Wendy G. Tan
Human Drugs Form 483
FDA 483 Rentschler Biopharma SE, Laupheim | 2023
Out-of-stock
Wendy G. Tan
Human Drugs Form 483
FDA 483 Vetter Pharma Fertigung GmbH & Co. KG, Langenargen | 2023
Out-of-stock
Wendy G. Tan
Human Drugs Form 483
FDA 483 Lilly France S.A.S., Fegersheim | 2022
Out-of-stock
Wendy G. Tan
Human Drug Form 483
FDA 483 Biogen U.S. Corporation, Research Triangle Park | 2022
Out-of-stock
Wendy G. Tan
Human Drug Form 483
FDA 483 Roche Singapore Technical Operations Pte. Ltd., Singapore | 2022
Out-of-stock
Wendy G. Tan
Human Drug Form 483
FDA 483 SEAGEN INC., Bothell | 2022
Out-of-stock
Wendy G. Tan
Human Drug Form 483
FDA 483 Lyocontract GmbH, Ilsenburg (Harz) | 2022
Out-of-stock
Wendy G. Tan
Human Drug Form 483
FDA 483 Kashiv BioSciences, LLC, Chicago | 2022
Out-of-stock
Wendy G. Tan
Human Drug Form 483
FDA 483 MSD International GmbH, Singapore | 2021
Out-of-stock
Wendy G. Tan
Human Drug Form 483
FDA 483 Rafa Laboratories Ltd., Jerusalem | 2017
Out-of-stock
Wendy G. Tan
Human Drug Form 483
FDA 483 Bausch & Lomb, Inc. a Division of Valeant Pharmaceuticals, Tampa | 2017
Out-of-stock
Wendy G. Tan
Human Drug Form 483
Co-Investigators (33)
- Alan L. Truong, FDA Investigator
- Rafeeq A. Habeeb, FDA Investigator
- Jacob G. Lutz, FDA Investigator
- Andrew J. Barrowcliff, FDA Investigator
- Charles Y. Kuo,
- Lane V. Christensen, FDA Investigator
- Yuan-Chia Kuo, FDA Investigator
- Caryn M. McNab, FDA Investigator
- Hamet M. Toure, FDA Investigator
- Marcellinus D. Dordunoo, FDA Investigator
- Veronica Fuentes, FDA Investigator
- Song Y. Lavalais, FDA Investigator
- Esther C. Broner, FDA Investigator
- Katherine E. Jacobitz, FDA Investigator
- Riley C. Myers, FDA Investigator
- Christopher R. Czajka, FDA Investigator
- Jacek Cieslak, FDA Investigator
- Nibin Varghese, FDA Investigator
- Maria G. Gutierrez-Hoffman, FDA Investigator
- Rong Wang, FDA Investigator
- Thuy T. Nguyen, FDA Investigator
- Zhihao Pete Qiu, FDA Investigator
- Lauren N. Howard, FDA Investigator
- Cassandra L. Abellard, FDA Investigator
- Jose O. Hernandez, FDA Investigator
- Marion Michaelis, FDA Investigator
- Jennifer L. Huntington, FDA Investigator
- Ileana Barreto-Pettit, FDA Investigator
- Ruo H. Xu, FDA Investigator
- Bijoy Panicker, FDA Investigator
- Patric C. Klotzbuecher, FDA Investigator
- Brian J. Ryan, FDA Investigator
- Charanjeet Jassal, FDA Investigator